Sei Investments Co. lifted its stake in shares of Cigna Group (NYSE:CI – Free Report) by 83.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 865,893 shares of the health services provider’s stock after purchasing an additional 394,294 shares during the quarter. Sei Investments Co.’s holdings in Cigna Group were worth $230,976,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Wilkerson Advisory Group LLC purchased a new position in Cigna Group during the 4th quarter worth $25,000. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group during the fourth quarter worth about $28,000. Cedar Mountain Advisors LLC raised its holdings in Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group in the fourth quarter valued at about $29,000. Finally, Prosperity Bancshares Inc acquired a new stake in Cigna Group in the fourth quarter valued at about $29,000. 86.99% of the stock is owned by institutional investors and hedge funds.
Cigna Group Price Performance
Cigna Group stock opened at $285.29 on Thursday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm’s 50-day simple moving average is $286.11 and its 200 day simple moving average is $280.66. The firm has a market capitalization of $75.47 billion, a PE ratio of 12.09, a P/E/G ratio of 1.12 and a beta of 0.29.
Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is 26.45%.
Analyst Ratings Changes
Several equities analysts have issued reports on CI shares. Mizuho boosted their target price on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Piper Sandler reduced their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Cantor Fitzgerald lifted their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Sanford C. Bernstein upped their price objective on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Finally, Raymond James Financial set a $340.00 price objective on Cigna Group in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.
Insider Buying and Selling at Cigna Group
In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
